Showing results (591-600 of 735) with videos related to
Sort By:
Pageof 74
European Journal of Cancer & Clinical Oncology|February 1, 1989
Three-year disease-free survivors of small cell lung cancer treated with combination chemotherapy with or without chest irradiationM Fukuoka, N Masuda, K Matsui, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1988
[Studies on an appropriate intra thoracic administration of cisplatin and sodium thiosulfate in malignant pleural effusion]K Kitajima, M Fukuoka, Y Kusunoki, et al.Cancer|March 15, 1994
Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancerS Imamura, Y Kusunoki, N Takifuji, et al.Acta Pathologica Japonica|May 1, 1984
Restoration of antigenicity of tissue antigens, cell-bound immunoglobulins and immune deposits in paraffin-embedded tissue. The influence of fixation and proteolytic enzymatic digestionY Suzuki, A Maesawa, K Matsui, et al.Arzneimittel-Forschung|January 1, 1989
Restorative effect of muroctasin on leukopenia caused by anticancer chemotherapy in lung cancer. Comparative study by envelope methodM Fukuoka, M Takada, N Takifuji, et al.European Journal of Gynaecological Oncology|March 25, 2014
Evaluation of primary prophylaxis with granulocyte colony-stimulating factor for epithelial ovarian cancerK Matsui, T Mori, M Sawada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1985
[Response and pharmacokinetics of cisplatin instilled into the pleural cavity]S Kudoh, N Takifugi, S Ryu, et al.Blood|June 22, 2001
Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host diseaseH Itoi, Y Fujimori, H Tsutsui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancerN Masuda, M Fukuoka, S Kudoh, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1988
[Phase II studies of a single agent and a cis-platinum-based two-drug combination in patients with non-small cell lung cancer]M Yamamoto, K Furuse, M Fukuoka, et al.Pageof 74